Abbott Laboratories price to sales ratio ABT

Market value divided by revenue over the last twelve months, since 2010.

Today, Oct 23, 2026: n/m; a quarter missing
10-year median: 4.5×
10-year range: 2.7× to 7.1×
Peer median: 3.3×

Abbott Laboratories' price to sales ratio can't be checked today: its revenue for Q3 FY26, the quarter to Sep 30, 2026, is missing from our data, so the twelve months it rests on can't be added up.

On the days it had one over the last ten years, its median was 4.5×, from 2.7× in Dec 2016 to 7.1× in Feb 2021.

Price to sales ratio over time

median 4.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.9×	3.3×	5.0×
2025	5.0×	4.7×	5.7×
2024	4.8×	4.4×	5.2×
2023	4.8×	3.9×	4.8×
2022	4.3×	3.7×	5.7×
2021	5.9×	5.2×	7.1×
2020	6.0×	3.8×	6.3×
2019	4.9×	3.9×	5.0×
2018	4.1×	3.6×	4.4×
2017	4.0×	2.9×	4.1×
2016	2.7×	2.7×	3.2×
2015	3.3×	3.0×	3.7×
2014	3.2×	2.1×	3.2×
2013	2.2×	1.3×	2.2×
2012	1.2×	1.1×	1.4×
2011	1.1×	1.0×	1.1×
2010	1.0×	1.0×	1.2×

Against its peers

Companies in Medical - Devices nearest Abbott Laboratories' size, closest first, today.

Company	Price to sales ratio
ABTAbbott Laboratories	n/m
MDTMedtronic	3.3×
SYKStryker	4.6×
BSXBoston Scientific	3.2×
EWEdwards Lifesciences	7.9×
GEHCGE HealthCare Technologies	1.5×
DXCMDexCom	5.9×
ZBHZimmer Biomet	2.2×
Peer median	3.3×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Abbott Laboratories

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.